1. Home
  2. AERT vs PASG Comparison

AERT vs PASG Comparison

Compare AERT & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

HOLD

Current Price

$0.53

Market Cap

27.9M

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$12.81

Market Cap

28.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AERT
PASG
Founded
2012
2017
Country
Singapore
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
28.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AERT
PASG
Price
$0.53
$12.81
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$34.50
AVG Volume (30 Days)
61.0K
84.1K
Earning Date
02-13-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$69,346,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$5.12
52 Week High
$1.52
$20.00

Technical Indicators

Market Signals
Indicator
AERT
PASG
Relative Strength Index (RSI) 45.22 48.79
Support Level $0.51 $13.33
Resistance Level $0.54 $16.12
Average True Range (ATR) 0.02 2.26
MACD 0.00 -0.28
Stochastic Oscillator 42.41 31.51

Price Performance

Historical Comparison
AERT
PASG

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: